UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): February 3, 2004
EDWARDS LIFESCIENCES CORPORATION
(Exact name of registrant as specified in its charter)
Delaware |
| 1-15525 |
| 36-4316614 |
(State or other jurisdiction |
| (Commission |
| (IRS Employer |
One Edwards Way, Irvine, California |
| 92614 |
(Address of principal executive offices) |
| (Zip Code) |
(949) 250-2500
Registrant’s telephone number, including area code
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) Exhibits
99.1 Press release, dated February 3, 2004, reporting Edwards’ financial results for the fourth quarter of 2003 and the year ended December 31, 2003.
Item 12. Disclosure of Results of Operations and Financial Condition.
The following information and the exhibit attached hereto are furnished pursuant to Item 12—Disclosure of Results of Operations and Financial Condition.
On February 3, 2004, Edwards Lifesciences Corporation, a Delaware corporation (“Edwards”), issued a press release setting forth Edwards’ financial results for the fourth quarter of 2003 and the year ended December 31, 2003. A copy of the press release is attached as Exhibit 99.1.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: February 3, 2004
| EDWARDS LIFESCIENCES CORPORATION | ||
|
| ||
|
| ||
| By: | /s/ Bruce P. Garren |
|
|
| Bruce P. Garren | |
|
| Corporate Vice President, | |
|
| General Counsel and Secretary | |
3
Exhibit Index
Exhibit |
| Description |
|
|
|
99.1 |
| Press release, dated February 3, 2004, reporting Edwards’ financial results for the fourth quarter of 2003 and the year ended December 31, 2003. |
4